drugset / Trial / NCT06482541
Efficacy and Safety Of AGE ZERO™ EXOSOMES To Treat Men and Women With Androgenetic Alopecia
Phase 1
Not yet recruiting
100 enrolled
Levit Dermatology
Dorisca Research Consulting, LLC · collabResilielleTM Age ZeroTM Exosomes · collab
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The purpose of this study is to determine whether Wharton's Jelly mesenchymal stem cell-derived exosome microneedling on the scalp is an effective treatment for Androgenetic Alopecia (pattern hair loss).
Timeline
- Start
- 2024-07
- Primary completion
- 2025-07
- Completion
- 2025-08
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | WJMSC-exosome | Other / unclassified | 5 unknown | Topical |
| Subject | WJMSC-exosome | Other / unclassified | 50 unknown | Topical |